Form 8-K - Current report:
SEC Accession No. 0001657312-23-000003
Filing Date
2023-03-07
Accepted
2023-03-07 06:06:44
Documents
14
Period of Report
2023-03-07
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K vrna-20230307.htm   iXBRL 8-K 47764
2 EX-99.1 vrna2022pressreleasefinal.htm EX-99.1 71897
6 GRAPHIC image_0a.jpg GRAPHIC 111995
  Complete submission text file 0001657312-23-000003.txt   424396

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20230307.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20230307_lab.xml EX-101.LAB 24633
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20230307_pre.xml EX-101.PRE 12986
8 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20230307_htm.xml XML 11221
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 23710954
SIC: 2834 Pharmaceutical Preparations